Chloroquine and COVID-19: A western medical and scientific drift?
作者信息
Million Matthieu, Roussel Yanis, Raoult Didier
机构信息
IHU-Méditerranée Infection, Marseille, France; Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France.
出版信息
Eur J Intern Med. 2020 Aug;78:4-5. doi: 10.1016/j.ejim.2020.06.020. Epub 2020 Jun 23.
Abstract
摘要
相似文献
1
Chloroquine and COVID-19: A western medical and scientific drift?氯喹与2019冠状病毒病：西方医学与科学的偏离？
Eur J Intern Med. 2020 Aug;78:4-5. doi: 10.1016/j.ejim.2020.06.020. Epub 2020 Jun 23.
2
Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?氯喹/羟氯喹在2019冠状病毒病（COVID-19）治疗中会有害吗？
Clin Infect Dis. 2020 Jul 28;71(15):888-889. doi: 10.1093/cid/ciaa321.
3
Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).关于氯喹/羟氯喹治疗 2019 年冠状病毒病（COVID-19）的最新情况。
Biosci Trends. 2020 May 21;14(2):156-158. doi: 10.5582/bst.2020.03072. Epub 2020 Apr 13.
4
Update Alert 2: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.更新警报2：羟氯喹或氯喹用于治疗或预防新型冠状病毒肺炎
Ann Intern Med. 2020 Oct 6;173(7):W128-W129. doi: 10.7326/L20-1054. Epub 2020 Aug 27.
5
Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.氯喹和羟氯喹在2019冠状病毒病中的应用：资源匮乏地区面临的挑战及谨慎使用的必要性
J Coll Physicians Surg Pak. 2020 Jun;30(6):78. doi: 10.29271/jcpsp.2020.Supp1.S78.
6
Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.使用氯喹和羟氯喹治疗COVID-19的心血管安全性最新研究结果
Am J Cardiol. 2020 Sep 1;130:162-163. doi: 10.1016/j.amjcard.2020.06.003. Epub 2020 Jun 9.
7
Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.氯喹和羟氯喹用于治疗新型冠状病毒肺炎：对心脏安全性的影响
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):256-257. doi: 10.1093/ehjcvp/pvaa041.
8
Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.最新警报2：临床医生应单独使用氯喹或羟氯喹，还是与阿奇霉素联合使用来预防或治疗新型冠状病毒肺炎？美国医师协会的临床实践要点
Ann Intern Med. 2020 Sep 1;173(5):W88-W89. doi: 10.7326/L20-1007. Epub 2020 Jul 30.
9
Chloroquine, Hydroxychloroquine, Retinal Toxicity, and COVID-19.氯喹、羟氯喹、视网膜毒性与2019冠状病毒病
Asia Pac J Ophthalmol (Phila). 2020 Jul-Aug;9(4):374. doi: 10.1097/APO.0000000000000315.
10
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.抗2019冠状病毒病（COVID-19）的氨基喹啉：氯喹或羟氯喹。
Int J Antimicrob Agents. 2020 Apr;55(4):105945. doi: 10.1016/j.ijantimicag.2020.105945. Epub 2020 Mar 17.
引用本文的文献
1
Rational for meta-analysis and randomized treatment: the COVID-19 example.荟萃分析与随机治疗的原理：以新冠疫情为例
Clin Microbiol Infect. 2021 Jan;27(1):6-8. doi: 10.1016/j.cmi.2020.10.012. Epub 2020 Oct 21.
2
Retrospective overview of a COVID-19 outbreak in Mauritania.毛里塔尼亚新冠肺炎疫情回顾
New Microbes New Infect. 2020 Nov;38:100788. doi: 10.1016/j.nmni.2020.100788. Epub 2020 Oct 15.
3
Familiar Dermatologic Drugs as Therapies for COVID-19.常见皮肤科药物在 COVID-19 治疗中的应用。
Actas Dermosifiliogr (Engl Ed). 2021 Feb;112(2):118-126. doi: 10.1016/j.ad.2020.09.004. Epub 2020 Oct 10.
4
COVID-19 and hydroxychloroquine: Let the available data speak for themselves.新型冠状病毒肺炎与羟氯喹：让现有数据来说话。
Eur J Intern Med. 2020 Oct;80:121. doi: 10.1016/j.ejim.2020.07.017. Epub 2020 Jul 21.
本文引用的文献
1
Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world.氯喹衍生物在新型冠状病毒肺炎感染中的临床疗效：大数据与真实世界的比较荟萃分析
New Microbes New Infect. 2020 Jun 6;38:100709. doi: 10.1016/j.nmni.2020.100709. eCollection 2020 Nov.
2
COVID-19 and hydroxychloroquine: Is the wonder drug failing?新冠病毒与羟氯喹：神药失效了吗？
Eur J Intern Med. 2020 Aug;78:1-3. doi: 10.1016/j.ejim.2020.06.002. Epub 2020 Jun 4.
3
Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤稿——羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎：一项多国注册研究分析
Lancet. 2020 Jun 13;395(10240):1820. doi: 10.1016/S0140-6736(20)31324-6. Epub 2020 Jun 5.
4
Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.关注声明：羟氯喹啉或氯喹啉联合或不联合大环内酯类药物治疗COVID-19：一项多国注册分析
Lancet. 2020 Jun 13;395(10240):e102. doi: 10.1016/S0140-6736(20)31290-3. Epub 2020 Jun 3.
5
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为 COVID-19 暴露后预防的随机试验。
N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.
6
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.撤回：羟氯喹或氯喹联合或不联合大环内酯类药物治疗新型冠状病毒肺炎：一项多国注册分析
Lancet. 2020 May 22. doi: 10.1016/S0140-6736(20)31180-6.
7
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial.羟氯喹治疗主要为轻症和中症的 2019 冠状病毒病患者：开放标签、随机对照试验。
BMJ. 2020 May 14;369:m1849. doi: 10.1136/bmj.m1849.
8
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data.羟氯喹治疗需要吸氧的 COVID-19 肺炎患者的临床疗效：利用常规护理数据进行的观察性对比研究。
BMJ. 2020 May 14;369:m1844. doi: 10.1136/bmj.m1844.
9
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.羟氯喹和阿奇霉素联合治疗 COVID-19 患者：法国马赛 1061 例回顾性分析。
Travel Med Infect Dis. 2020 May-Jun;35:101738. doi: 10.1016/j.tmaid.2020.101738. Epub 2020 May 5.
Zotero 插件